PEGylation: An approach for drug delivery. A review

被引：158

作者：

Jain, Aviral ^{[1
]}

Jain, Sanjay K. ^{[1
]}

机构：

[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar 470003, MP, India

来源：

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2008年 / 25卷 / 05期

关键词：

PEGylation; PEG; RES uptake; protein conjugates;

D O I：

10.1615/CritRevTherDrugCarrierSyst.v25.i5.10

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The current review presents an update on polyethylene glycol (PEG), which is widely used as a covalent modifier of macromolecules. This review discusses the polymers suitable for conjugation, their conjugation methods, and their properties. Proteins and bioactive substances can be chemically modified by binding synthetic macromolecules of PEG to the surface of these biomolecules. Protein and peptide PEGylation improves the biopharmaceutical properties of drugs-that is, increased stability, increased resistance to proteolytic inactivation, decreased to nonexistent immunogenicity, increased circulatory lives, and low toxicity. These altered properties improve the delivery and efficacy of proteins.

引用

页码：403 / 447

页数：45

共 189 条

[71] Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer [J].